Positive Bloodstream Tuberculosis Induced T Cell Based Interferon Gamma Release Assay C5970260
A blood test indicating the immune system has responded to tuberculosis bacteria, suggesting TB infection. Additional tests are needed to confirm active disease and guide treatment.
Key facts at a glance
- ICD-10
- B99.9
- ICD-11
- 1A00.0
- Body system
- infectious
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fever or malaise
(infectious)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Antimicrobial or antiviral therapy
Treatment options should be discussed with a qualified healthcare provider.
Latent TB infection treatment
Preventive antibiotic therapy (typically isoniazid, rifapentine, or rifampin-based regimens) to eliminate dormant Mycobacterium tuberculosis and prevent progression to active disease.
Contact investigation and screening
Systematic identification and testing of close contacts to detect additional TB infections and prevent community transmission through early intervention.
Additional treatment options
Treatment adherence support
Directly observed therapy or digital adherence technologies to ensure completion of lengthy TB preventive treatment and prevent drug resistance.
monitoringNutritional support
Optimization of nutritional status including vitamin D, zinc, and protein intake to support immune function and improve treatment outcomes.
dietaryRespiratory isolation protocols
Infection control measures including mask use, negative pressure rooms, and respiratory hygiene when active TB disease is suspected or confirmed.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Positive Bloodstream Tuberculosis Induced T Cell Based Interferon Gamma Release Assay C5970260?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Centers for Disease Control and Prevention. Guidelines for the Application of Interferon-Gamma Release Assays for Tuberculosis Diagnosis. MMWR Recomm Rep. 2022.
Pai M, Zwerling A, Menzies D. Systematic Review of T-Cell Based Interferon-Gamma Release Assays for Diagnosis of Latent TB Infection. PLoS Med. 2018.
Sester M, van Leth F, Lange R. Interferon-Gamma Release Assays for the Diagnosis of Active Tuberculosis. Clin Infect Dis. 2021.
Lee YM, Kim SJ, Park SH. Evaluation of IGRA Performance in Bloodstream Tuberculosis Infection. J Clin Microbiol. 2020.
Medication Comparisons
Compare medications used to treat Positive Bloodstream Tuberculosis Induced T Cell Based Interferon Gamma Release Assay C5970260. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy